Mette Gislum

3.1k total citations · 2 hit papers
40 papers, 2.1k citations indexed

About

Mette Gislum is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Mette Gislum has authored 40 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Mette Gislum's work include Global Cancer Incidence and Screening (7 papers), Diabetes Treatment and Management (7 papers) and Colorectal Cancer Screening and Detection (6 papers). Mette Gislum is often cited by papers focused on Global Cancer Incidence and Screening (7 papers), Diabetes Treatment and Management (7 papers) and Colorectal Cancer Screening and Detection (6 papers). Mette Gislum collaborates with scholars based in Denmark, United States and Finland. Mette Gislum's co-authors include Gerda Engholm, Henrik Toft Sørensen, Freddie Bray, Timo Hakulinen, Hans H. Storm, Åsa Klint, Laufey Tryggvadóttír, Søren Paaske Johnsen, Torben Bjerregaard Larsen and Lars Pedersen and has published in prestigious journals such as New England Journal of Medicine, Diabetes and European Heart Journal.

In The Last Decade

Mette Gislum

38 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

2023 147 citations Mette Gislum, Johannes F.E. Mann et al. profile →
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes

2025 89 citations Darren K. McGuire, Nikolaus Marx et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Mette Gislum

Since Specialization

Citations

This map shows the geographic impact of Mette Gislum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Gislum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Gislum more than expected).

Fields of papers citing papers by Mette Gislum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Gislum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Gislum. The network helps show where Mette Gislum may publish in the future.

Co-authorship network of co-authors of Mette Gislum

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Gislum. A scholar is included among the top collaborators of Mette Gislum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Gislum. Mette Gislum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes breakdown → 2025 ·New England Journal of Medicine ·Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, John Deanfield, Silvio E. Inzucchi, Rodica Pop‐Busui, Johannes F.E. Mann, Scott S. Emerson, Neil R Poulter, Mads D.M. Engelmann, Maria Sejersten Ripa, G. Kees Hovingh, Kirstine Brown‐Frandsen, Stephen C. Bain, Matthew A. Cavender, Mette Gislum, (unknown), John B. Buse	89
2	Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses 2021 ·Diabetes Therapy ·Richard E. Pratley, Matthew J. Crowley, Mette Gislum, CHRISTIN L. HERTZ, Thomas Bo Jensen, Kamlesh Khunti, Ofri Mosenzon, John B. Buse	12
3	Trends in the survival of patients diagnosed with cancers in the respiratory system in the Nordic countries 1964–2003 followed up to the end of 2006 2010 ·Acta Oncologica ·Timo Hakulinen, Gerda Engholm, Mette Gislum, Hans H. Storm, Åsa Klint, Laufey Tryggvadóttír, Freddie Bray	31
4	Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006 2010 ·Acta Oncologica ·Åsa Klint, Gerda Engholm, Hans H. Storm, Laufey Tryggvadóttír, Mette Gislum, Timo Hakulinen, Freddie Bray	94
5	Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006 2010 ·Acta Oncologica ·Hans H. Storm, Åsa Klint, Laufey Tryggvadóttír, Mette Gislum, Gerda Engholm, Freddie Bray, Timo Hakulinen	50
6	Survival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the results 2010 ·Acta Oncologica ·Hans H. Storm, Gerda Engholm, Timo Hakulinen, Laufey Tryggvadóttír, Åsa Klint, Mette Gislum, Anne Mette Tranberg Kejs, Freddie Bray	64
7	Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964–2003 followed up to the end of 2006 2010 ·Acta Oncologica ·Laufey Tryggvadóttír, Mette Gislum, Timo Hakulinen, Åsa Klint, Gerda Engholm, Hans H. Storm, Freddie Bray	53
8	Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006 2010 ·Acta Oncologica ·Freddie Bray, Åsa Klint, Mette Gislum, Timo Hakulinen, Gerda Engholm, Laufey Tryggvadóttír, Hans H. Storm	42
9	Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964–2003 followed up until the end of 2006 2010 ·Acta Oncologica ·Freddie Bray, Gerda Engholm, Timo Hakulinen, Mette Gislum, Laufey Tryggvadóttír, Hans H. Storm, Åsa Klint	27
10	Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods 2010 ·Acta Oncologica ·Gerda Engholm, Mette Gislum, Freddie Bray, Timo Hakulinen	50
11	Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: A population-based nested case-control study 2007 ·Thrombosis Research ·Torben Bjerregaard Larsen, Henrik Toft Sørensen, Mette Gislum, Søren Paaske Johnsen	171
12	Temporal trends of aeroallergen sensitization over twenty‐five years 2007 ·Clinical & Experimental Allergy ·Allan Linneberg, Mette Gislum, Niels Johansen, Lise Lotte N. Husemoen, Torben Jørgensen	58
13	Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations 2006 ·Epidemiology ·Pia Wogelius, Mette Nørgaard, Mette Gislum, Lars Pedersen, Estrid Muff Munk, Preben Bo Mortensen, Loren Lipworth, Henrik Toft Sørensen	144
14	Fracture risk in patients with monoclonal gammopathy of undetermined significance 2006 ·British Journal of Haematology ·Henrik Gregersen, Paw Jensen, Mette Gislum, (unknown), Henrik Toft Sørensen, Mette Nørgaard	36
15	Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study 2006 ·Alimentary Pharmacology & Therapeutics ·Vivian Langagergaard, Lars Pedersen, Mette Gislum, Bente Mertz Nørgård, Henrik Toft Sørensen	69
16	Survival After Colorectal Cancer in Patients with Ulcerative Colitis: A Nationwide Population-Based Danish Study 2006 ·The American Journal of Gastroenterology ·(unknown), Mette Bach Larsen, Mette Gislum, Mette Vinther Skriver, Peter Jepsen, (unknown), Henrik Toft Sørensen	80
17	Survival After Colorectal Cancer in Patients with Crohn's Disease: A Nationwide Population-Based Danish Follow-Up Study 2006 ·The American Journal of Gastroenterology ·Mette Bach Larsen, (unknown), Mette Gislum, Mette Vinther Skriver, Peter Jepsen, Bente Mertz Nørgård, Henrik Toft Sørensen	44
18	ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population‐based, nested case–control study 2005 ·Journal of Thrombosis and Haemostasis ·Torben Bjerregaard Larsen, Søren Paaske Johnsen, Mette Gislum, Charlotte Møller, Helle Larsen, Henrik Toft Sørensen	55
19	Birth outcome in women with breast cancer 2005 ·British Journal of Cancer ·Vivian Langagergaard, Mette Gislum, Mette Vinther Skriver, Bente Mertz Nørgård, Timothy L. Lash, Kenneth J. Rothman, Henrik Toft Sørensen	61
20	Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones 2005 ·International Journal of Antimicrobial Agents ·Pia Wogelius, Mette Nørgaard, Mette Gislum, Lars Pedersen, Henrik Carl Schønheyder, Henrik Toft Sørensen	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact